FDA drug center head expected to leave after commissioner's exit, sources say
The move deepens a leadership shake-up at the agency as officials close to Marty Makary and Robert F. Kennedy Jr. continue to depart.
- On Friday, the FDA announced that Tracy Beth Hoeg is stepping down as acting drug center director, with Mike Davis, the center's deputy director, replacing her.
- Hoeg's departure marks the latest transition in an ongoing shake-up at the FDA, following FDA Commissioner Marty Makary's resignation earlier this week and Vinay Prasad's departure last month.
- During her tenure, Hoeg conducted an "initial analysis" linking COVID-19 vaccines to 10 reported deaths in children without providing evidence, while remaining closely aligned with Makary and Health Secretary Robert.
- The agency also announced Friday that Karim Mikhail, a longtime pharmaceutical executive hired by Makary last spring, will assume the role of acting vaccines center director.
- Hoeg's exit underscores a revolving door of leadership changes at the agency, where recent appointees including her lacked the decades of career scientific experience typically required for center director positions.
66 Articles
66 Articles
RFK ally confirms she was fired by FDA: 'I learned so much and leave with no regrets'
A Food and Drug Administration official involved in scrutinizing the safety of antidepressants, COVID-19 vaccines and other widely used therapies has been removed from her role leading the agency’s drug program. Dr. Tracy Beth Hoeg will be replaced as FDA’s acting drug center director by Dr. Mike Davis, who has been serving as deputy director, according to an email sent to agency staff Friday that was obtained by The Associated Press. Hoeg said …
FDA shakeup continues with departure of top drug regulator, just days after agency chief resigns
Dr. Tracy Beth Høeg is leaving her role as head of the FDA division that regulates over-the-counter and prescription drugs, according to a Department of Health and Human Services official. Høeg, a sports medicine doctor who criticized Covid shots for children during the pandemic, served as acting director of the Food and Drug Administration’s Center for Drug Evaluation and Research for about five months. She was the fifth person to hold the post…
FDA official who scrutinized COVID shots and antidepressants is out in latest shake-up
The Food and Drug Administration's top drug official is leaving in the latest shake-up at the powerful health agency. Dr.
Coverage Details
Bias Distribution
- 51% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium





















